Phost'in Therapeutics

Phost'in Therapeutics Develops New Chemical Entities Focusing on Treating Abnormal Glycosylation Mechanisms and Cancer. The company’s chemical entities are dedicated to the discovery and development of NCEs specifically targeting pathogenic glycosylation mechanisms, enabling healthcare providers to effectively treat cancer and other serious diseases.